In addition, they have found that eicosapentaenoic acid ethyl ester (EPA) can also increase the expression of miR-378 in BRAF- and KRAS-mutant CRC cells and resensitize KRAS-mutant CRC cells to cetuximab (49). Here, KRAS is linked to colorectal carcinoma.